|
1
|
Krishnamurthi K: Screening of naturla
products for anticancer and antidiabetic properties. Health
Administrator. XX:69–75. 2000.
|
|
2
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seyfried TN and Huysentruyt LC: On the
origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013.
View Article : Google Scholar :
|
|
4
|
Wells A, Grahovac J, Wheeler S, Ma B and
Lauffenburger D: Targeting tumor cell motility as a strategy
against invasion and metastasis. Trends Pharmacol Sci. 34:283–289.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Steeg PS and Theodorescu D: Metastasis: A
therapeutic target for cancer. Nat Clin Pract Oncol. 5:206–219.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Agrawal A, Dang S and Gabrani R: Recent
patents on anti-telomerase cancer therapy. Recent Patents
Anticancer Drug Discov. 7:102–117. 2012. View Article : Google Scholar
|
|
7
|
Holysz H, Lipinska N, Paszel-Jaworska A
and Rubis B: Telomerase as a useful target in cancer fighting-the
breast cancer case. Tumour Biol. 34:1371–1380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim NW, Piatyszek MA, Prowse KR, Harley
CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay
JW: Specific association of human telomerase activity with immortal
cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jafri MA, Ansari SA, Alqahtani MH and Shay
JW: Roles of telomeres and telomerase in cancer, and advances in
telomerase-targeted therapies. Genome Med. 8:69–88. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Demain AL and Vaishnav P: Natural products
for cancer chemotherapy. Microb Biotechnol. 4:687–699. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Norikura T, Kojima-Yuasa A, Shimizu M,
Huang X, Xu S, Kametani S, Rho SN, Kennedy DO and Matsui-Yuasa I:
Mechanism of growth inhibitory effect of Blumea balsamifera extract
in hepatocellular carcinoma. Biosci Biotechnol Biochem.
72:1183–1189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Machana S, Weerapreeyakul N, Barusrux S,
Thumanu K and Tanthanuch W: Synergistic anticancer effect of the
extracts from Polyalthia evecta caused apoptosis in human hepatoma
(HepG2) cells. Asian Pac J Trop Biomed. 2:589–596. 2012. View Article : Google Scholar
|
|
13
|
Huxley CR: The ant-plants Myrmecodia and
Hydnophytum (Rubiaceae), and the relationships between their
morphology, ant occupants, physiology and ecology. New Phytol.
80:231–268. 1978. View Article : Google Scholar
|
|
14
|
Lok AFSL and Tan HTW: Tuberous, epiphytic,
rubiaceous myrmecophytes of singapore. Nat Singap. 2:231–236.
2009.
|
|
15
|
Subroto MA and Saputro H: Gempur Penyakit
Dengan Sarang Semut. Jakarta Penebar Swadaya. 11–22. 2006.In
Indonesian.
|
|
16
|
Soeksmanto A, Subroto MA, Wijaya H and
Simanjuntak P: Anticancer activity test for extracts of Sarang
semut plant (Myrmecodya pendens) to HeLa and MCM-B2 cells. Pak J
Biol Sci. 13:148–151. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Engida AM, Kasim NS, Tsigie YA, Ismadji S,
Huynh LH and Ju Y-H: Extraction, identification and quantitative
HPLC analysis of flavonoids from sarang semut (Myrmecodia pendan).
Ind Crops Prod. 41:392–396. 2013. View Article : Google Scholar
|
|
18
|
Yuletnawati SE, Meiyanto E and Agustina D:
High antitumor activity of ethanolic extracts of Papua's ant nest
plant (Myrmecodia tuberosa) on an oral carcinoma (KB) cell line.
Int J Sci Res. 5:1619–1623. 2016.
|
|
19
|
Sumardi, Hertiani T and Sasmito E: Ant
plant (Myrmecodia tuberosa) hypocotyl extract modulates
TCD4+ and TCD8+ cell profile of
doxorubicin-induced immune-suppressed sprague dawley rats in vivo.
Sci Pharm. 81:1057–1069. 2013. View Article : Google Scholar
|
|
20
|
Zhang XY, Li WG, Wu YJ and Gao MT:
Amelioration of doxorubicin-induced myocardial oxidative stress and
immunosuppression by grape seed proanthocyanidins in tumour-bearing
mice. J Pharm Pharmacol. 57:1043–1052. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sultana R, Di Domenico F, Tseng M, Cai J,
Noel T, Chelvarajan RL, Pierce WD, Cini C, Bondada S, Clair DK St,
et al: Doxorubicin-induced thymus senescence. J Proteome Res.
9:6232–6241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mohamad Haris NF, Nik Hasan MK, Wahab IA,
Hasan MH, Ponto T and Adam A: Compounds from the antioxidant active
fraction of M. platytyrea. J Sains Kesihatan Malaysia. 14:23–29.
2016. View Article : Google Scholar
|
|
23
|
Mizaton HH, Samad MA, Wahab IA, Mohamad
Haris NF, Ponto T and Adam A: Toxicological evaluation of
Myrmecodia platytyrea. 2010 International Conference on Science and
Social Research; Kuala Lumpur. 2010, View Article : Google Scholar
|
|
24
|
Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS,
Wu SH and Chung JG: Benzyl isothiocyanate (BITC) inhibits migration
and invasion of human colon cancer HT29 cells by inhibiting matrix
metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC
and MAPK signaling pathway. J Agric Food Chem. 58:2935–2942. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang L, Suwa T, Wright WE, Shay JW and
Hornsby PJ: Telomere shortening and decline in replicative
potential as a function of donor age in human adrenocortical cells.
Mech Ageing Dev. 122:1685–1694. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pascolo E, Wenz C, Lingner J, Hauel N,
Priepke H, Kauffmann I, Garin-Chesa P, Rettig WJ, Damm K and
Schnapp A: Mechanism of human telomerase inhibition by BIBR1532, a
synthetic, non-nucleosidic drug candidate. J Biol Chem.
277:15566–15572. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakamura TM, Morin GB, Chapman KB,
Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR:
Telomerase catalytic subunit homologs from fission yeast and human.
Science. 277:955–959. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Heine B, Hummel M, Demel G and Stein H:
Demonstration of constant upregulation of the telomerase RNA
component in human gastric carcinomas using in situ hybridization.
J Pathol. 185:139–144. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Le HTT, Cho YC and Cho S: Inhibition of
protein tyrosine phosphatase non-receptor type 2 by PTP inhibitor
XIX: Its role as a multiphosphatase inhibitor. BMB Rep. 50:329–334.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gattazzo F, Urciuolo A and Bonaldo P:
Extracellular matrix: A dynamic microenvironment for stem cell
niche. Biochim Biophys Acta. 1840:2506–2519. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ellerbroek SM and Stack MS: Membrane
associated matrix metalloproteinases in metastasis. BioEssays.
21:940–949. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Danø K, Rømer J, Nielsen BS, Bjørn S, Pyke
C, Rygaard J and Lund LR: Cancer invasion and tissue
remodeling--cooperation of protease systems and cell types. APMIS.
107:120–127. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Giannelli G, Bergamini C, Marinosci F,
Fransvea E, Quaranta M, Lupo L, Schiraldi O and Antonaci S:
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular
carcinoma. Int J Cancer. 97:425–431. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yeh HC, Lin SM, Chen MF, Pan TL, Wang PW
and Yeh CT: Evaluation of serum matrix metalloproteinase (MMP)-9 to
MMP-2 ratio as a biomarker in hepatocellular carcinoma.
Hepatogastroenterology. 57:98–102. 2010.PubMed/NCBI
|
|
36
|
Chen R, Cui J, Xu C, Xue T, Guo K, Gao D,
Liu Y, Ye S and Ren Z: The significance of MMP-9 over MMP-2 in HCC
invasiveness and recurrence of hepatocellular carcinoma after
curative resection. Ann Surg Oncol. 19(Suppl 3): S375–S384. 2012.
View Article : Google Scholar
|
|
37
|
Bernardes de Jesus B and Blasco MA:
Telomerase at the intersection of cancer and aging. Trends Genet.
29:513–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Padmanabhan P, Otero J, Ray P, Paulmurugan
R, Hoffman AR, Gambhir SS, Biswal S and Ulaner GA: Visualization of
telomerase reverse transcriptase (hTERT) promoter activity using a
trimodality fusion reporter construct. J Nucl Med. 47:270–277.
2006.PubMed/NCBI
|
|
39
|
Barma DK, Elayadi A, Falck JR and Corey
DR: Inhibition of telomerase by BIBR 1532 and related analogues.
Bioorg Med Chem Lett. 13:1333–1336. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Podlevsky JD, Bley CJ, Omana RV, Qi X and
Chen JJL: The telomerase database. Nucleic Acids Res. 36(Database):
D339–D343. 2008. View Article : Google Scholar :
|
|
41
|
Ulisse S, Baldini E, Sorrenti S and
D'Armiento M: The urokinase plasminogen activator system: A target
for anti-cancer therapy. Curr Cancer Drug Targets. 9:32–71. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Smith HW and Marshall CJ: Regulation of
cell signalling by uPAR. Nat Rev Mol Cell Biol. 11:23–36. 2010.
View Article : Google Scholar
|
|
43
|
Helbig G, Christopherson KW II,
Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and
Nakshatri H: NF-kappaB promotes breast cancer cell migration and
metastasis by inducing the expression of the chemokine receptor
CXCR4. J Biol Chem. 278:21631–21638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sen B and Johnson FM: Regulation of SRC
family kinases in human cancers. J Signal Transduct.
2011:8658192011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Noh H, Hong S and Huang S: Role of
urokinase receptor in tumor progression and development.
Theranostics. 3:487–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Steelman LS, Chappell WH, Abrams SL, Kempf
RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F,
Mazzarino MC, et al: Roles of the Raf/MEK/ERK and
PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity
to therapy-implications for cancer and aging. Aging (Albany NY).
3:192–222. 2011. View Article : Google Scholar
|
|
47
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chang HJ, Kim MH, Baek MK, Park JS, Chung
IJ, Shin BA, Ahn BW and Jung YD: Triptolide inhibits tumor
promoter-induced uPAR expression via blocking NF-kappaB signaling
in human gastric AGS cells. Anticancer Res. 27A:3411–3417.
2007.
|
|
49
|
Oeckinghaus A and Ghosh S: The NF-kappaB
family of transcription factors and its regulation. Cold Spring
Harb Perspect Biol. 1:a0000342009. View Article : Google Scholar
|
|
50
|
McGlynn KA and London WT: The global
epidemiology of hepatocellular carcinoma: Present and future. Clin
Liver Dis. 15:223–243. vii–x. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen C and Wang G: Mechanisms of
hepatocellular carcinoma and challenges and opportunities for
molecular targeted therapy. World J Hepatol. 7:1964–1970. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lu JJ, Pan W, Hu YJ and Wang YT:
Multi-target drugs: The trend of drug research and development.
PLoS One. 7:e402622012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tan W, Lu J, Huang M, Li Y, Chen M, Wu G,
Gong J, Zhong Z, Xu Z, Dang Y, et al: Anti-cancer natural products
isolated from chinese medicinal herbs. Chin Med. 6:272011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Srinivas NR: Baicalin, an emerging
multi-therapeutic agent: Pharmacodynamics, pharmacokinetics, and
considerations from drug development perspectives. Xenobiotica.
40:357–367. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Desai AG, Qazi GN, Ganju RK, El-Tamer M,
Singh J, Saxena AK, Bedi YS, Taneja SC and Bhat HK: Medicinal
plants and cancer chemoprevention. Curr Drug Metab. 9:581–591.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Avilés A, Arévila N, Díaz Maqueo JC, Gómez
T, García R and Nambo MJ: Late cardiac toxicity of doxorubicin,
epirubicin, and mitoxantrone therapy for Hodgkin's disease in
adults. Leuk Lymphoma. 1:275–279. 1993. View Article : Google Scholar
|
|
57
|
Macdonald JS: Toxicity of 5-fluorouracil.
Oncology (Williston Park). 13(Suppl 3): 33–34. 1999.
|
|
58
|
Adamson IY: Pulmonary toxicity of
bleomycin. Environ Health Perspect. 16:119–126. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Fraiser LH, Kanekal S and Kehrer JP:
Cyclophosphamide toxicity. Characterising and avoiding the problem.
Drugs. 42:781–795. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liang XJ, Chen C, Zhao Y and Wang PC:
Circumventing tumor resistance to chemotherapy by nanotechnology.
Methods Mol Biol. 596:467–488. 2010. View Article : Google Scholar
|
|
61
|
OECD: Acute oral toxicity. Acute oral
toxic class method guideline 423 adopted 23.03.1996. Eleventh
Addendum to the, OECD, guidelines for the testing of chemicals
organisation for economical co-operation and development Paris:
June. 2000
|
|
62
|
Skrzydlewska E, Sulkowska M, Koda M and
Sulkowski S: Proteolytic-antiproteolytic balance and its regulation
in carcinogenesis. World J Gastroenterol. 11:1251–1266. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Sakamoto Y, Mafune K, Mori M, Shiraishi T,
Imamura H, Mori M, Takayama T and Makuuchi M: Overexpression of
MMP-9 correlates with growth of small hepatocellular carcinoma. Int
J Oncol. 17:237–243. 2000.PubMed/NCBI
|
|
64
|
Shay JW and Bacchetti S: A survey of
telomerase activity in human cancer. Eur J Cancer. 33:787–791.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wright WE, Piatyszek MA, Rainey WE, Byrd W
and Shay JW: Telomerase activity in human germline and embryonic
tissues and cells. Dev Genet. 18:173–179. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Shay JW and Keith WN: Targeting telomerase
for cancer therapeutics. Br J Cancer. 98:677–683. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Collado M, Blasco MA and Serrano M:
Cellular senescence in cancer and aging. Cell. 130:223–233. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Meyerson M, Counter CM, Eaton EN, Ellisen
LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ,
Liu Q, et al: hEST2, the putative human telomerase catalytic
subunit gene, is up-regulated in tumor cells and during
immortalization. Cell. 90:785–795. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Maida Y, Kyo S, Kanaya T, Wang Z, Yatabe
N, Tanaka M, Nakamura M, Ohmichi M, Gotoh N, Murakami S, et al:
Direct activation of telomerase by EGF through Ets-mediated
transactivation of TERT via MAP kinase signaling pathway. Oncogene.
21:4071–4079. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kawauchi K, Ogasawara T, Yasuyama M,
Otsuka K and Yamada O: Regulation and importance of the
PI3K/Akt/mTOR signaling pathway in hematologic malignancies.
Anticancer Agents Med Chem. 9:1024–1038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Konnikova L, Simeone MC, Kruger MM,
Kotecki M and Cochran BH: Signal transducer and activator of
transcription 3 (STAT3) regulates human telomerase reverse
transcriptase (hTERT) expression in human cancer and primary cells.
Cancer Res. 65:6516–6520. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Bermudez Y, Yang H, Cheng JQ and Kruk PA:
Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of
telomerase activity by epidermal growth factor. Growth Factors.
26:1–11. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Shi H, Wu Y, Wang Y, Zhou M, Yan S, Chen
Z, Gu D and Cai Y: Liquiritigenin potentiates the inhibitory
effects of cisplatin on invasion and metastasis via downregulation
MMP-2/9 and PI3 K/AKT signaling pathway in B16F10 melanoma cells
and mice model. Nutr Cancer. 67:761–770. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chen J, Hou R, Zhang X, Ye Y, Wang Y and
Tian J: Calycosin suppresses breast cancer cell growth via
ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
PLoS One. 9:e912452014. View Article : Google Scholar
|
|
75
|
Kim YS, Li XF, Kang KH, Ryu B and Kim SK:
Stigmasterol isolated from marine microalgae Navicula incerta
induces apoptosis in human hepatoma HepG2 cells. BMB Rep.
47:433–438. 2014. View Article : Google Scholar :
|
